Send us a text

Dr Farzana Hussain (GP Principal, The Project Surgery) and Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) explore the unmet needs of Primary Care Networks (PCNs) and how industry can best support primary care leaders and GPs as we head into winter, 2024 and beyond.

Former ‘GP of the year’ and strategic influencer over primary care policy, Dr Farzana Hussain, discusses the unmet needs in primary care, how primary care leaders are responding to these challenges, and where industry can best offer support.

Phil and Farzana discuss:

•  How unmet needs are identified in primary care, the processes followed, and datasets used to inform decision making
•  The specific challenges facing primary care as we head into winter
•  The role of PCN leaders and their impact on national policy
•  How industry can best support and collaborate with PCNs
•  Ongoing lessons from the pandemic and the vaccine roll-out

Learn more about this webinar at: https://mtechaccess.co.uk/unmet-need-nhs-primary-care/

Discover or NHS Insight and UK market access services: https://mtechaccess.co.uk/uk-nhs-insights/

This episode was first broadcast as a live webinar in October 2023. 

Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

Send us a text

How can our community support NHS leaders to deliver a data-led, people-centric health service?

Dr Mark Davies (Global Chief Health Officer, IBM) joins Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) to explore the power of data, the role of community and how the health and life sciences ecosystem can support the NHS’s population health management goals.

Population health management has the potential to be a powerful tool for healthcare systems, effecting the way health and care is strategised, budgeted, targeted, and delivered. We see a future where key decisions in the NHS are driven by population health data. What we now need is a new way of working powered by local need, quality evidence and a systematic approach.

In this webinar, Phil and Mark explore:

 - How the NHS can use population health management to transform the system
 - The importance of community in population health management
 - How Pharma, Medtech, and the wider life sciences sector can work above brand to support the NHS with population health management
 - What a data-driven, people-centric approach means for the way treatments are valued
 - How population health management could transform the economics of healthcare

This episode was first broadcast as a live webinar on Friday 8th September 2023. Learn more at: https://mtechaccess.co.uk/uk-nhs-insights/

Discover more about our work in this area at: https://mtechaccess.co.uk/uk-nhs-insights/

Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

Send us a text

How is Artificial Intelligence being used in the development of new medicines? What role can AI currently play in clinical trials? Where can AI bridge gaps and solve challenges? What could this mean for the future of market access?

In this webinar, Dr George Magrath explains how his team at Lexitas are using AI in clinical trials in the field of ophthalmology. George and Calum explore:

- How, when and where AI is being used in clinical trials
- How Lexitas are using AI in clinical trials for ophthalmology
- Where AI may offer solutions to existing obstacles in clinical trials and ophthalmic drug development
- What the future holds for AI in the development of new medicines
- The role AI can play in selecting patients for clinical trials
- The impact AI may have on the way we evaluate drug effectiveness
- What this all means for evidence synthesis, health economics, reimbursement and market access
- The future prospects of AI in pharmaceutical development

Learn more at: https://mtechaccess.co.uk/ai-clinical-trials-evidence/

This episode was first broadcast as a live webinar in August 2023. 

Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

Send us a text

How is the UK political landscape evolving and what does this mean for Health Technology and Medical Device innovators?

Robert Hull (Senior Consultant – NHS Insight & Interaction, Mtech Access) speaks to William Lee (Head of Policy and Compliance, British Healthcare Trades Association [BHTA]) about health policy, regulation and its implications for Medtech, Health technologies, and Medical Device market access.

With the challenges of the pandemic and the changes brought in following Brexit, policy and compliance in the UK has been on shifting sands for several years now. With many predicting a change in government at the next election, this continues to be a time of uncertainty. What does this political landscape mean for health policy, the regulatory regime and market access?

In this on-demand webinar, Rob asks Bill about 6 areas where Medtech should be paying attention:

• MHRA and new medical device regulatory regime
• UK health and social care supply and procurement
• Sustainability and social value
• Addressing capacity challenges with effective health and social care packages
• Innovation
• Export and import – the implications of Brexit

This episode was first broadcast as a live webinar in July 2023.  Learn more about this webinar at:  https://mtechaccess.co.uk/uk-health-policy-medtech-bhta-webinar/

Learn more about our services for Medtech companies at: https://mtechaccess.co.uk/medical-device-market-access/

Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

Send us a text

Here we explore market access challenges in Germany, Austria and Switzerland. Clare Foy (Global Market Access Director – Mtech Access) speaks to Dr Stefan Walzer (CEO, President & Founder at MArS Market Access & Pricing Strategy GmbH) about the challenges and opportunities for reimbursement in the German-speaking markets.

Clare and Stefan discuss:
 - Preparing for access to Switzerland – a European market outside the EU
 - Pricing strategy and HTA decision-making in Austria under the new Ludwig Boltzmann Institute for Health Technology Assessment (LBI-HTA)
 - Launching in Germany – is this still one of the most attractive European markets?
 - The Financial Stabilisation Act in Germany – what this means for drug pricing

Learn more at: https://mtechaccess.co.uk/market-acce...

This episode was first broadcast as a live webinar in July 2023. 

Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

Send us a text

How are nursing professionals supporting the digital evolution in UK healthcare? How can new technologies be leveraged by front-line clinical teams to support improved patient care? And how can Medtech, Digital and Biotech innovators collaborate with the front-line nursing teams in the NHS to drive transformation?

Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) speaks to Jennie Smith, registered nurse, Medtech launch specialist and our new Director of NHS Insight & Interaction at Mtech Access.

Phil and Jennie explore:

 - The transformative power of technology in the NHS; particularly on patient pathways
 - The role of nurses in digital transformation and the adoption and implementation of new technologies
 - Key nursing champions, including Chief Nurse Information Officers (CNIOs)
 - How industry can best support the NHS with digital transformation
 - Our plans to bring together NHS and industry for greater collaboration

This episode was originally broadcast as a live webinar in June 2023. Learn more at: https://mtechaccess.co.uk/nursing-driving-digital-change-nhs/

Learn more about our NHS Insight & Interaction services at: https://mtechaccess.co.uk/uk-nhs-insights/

Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

Send us a text

In this Global Whispers webinar we explore market access for digital therapeutics. Clare Foy (Global Market Access Director – Mtech Access) speaks to Shefali Shah (Global VP, Market Value and Commercial Effectiveness – MindMaze) about the challenges and opportunities for digital therapies to gain market access and ultimately improve patient outcomes.

In the webinar, Clare asks Shefali about:

• The opportunities for digital technologies in neurology and how they may impact existing care pathways in the future
• How the digital technology market differs from the pharmaceutical market
• Regulatory and reimbursement challenges for digital technologies
• Her experiences in launching digital technologies in markets such as the US and Germany
• How digital technologies can be used to enhance and complement existing treatments/pathways of care
• Lessons other digital health, medical device and pharmaceutical companies can learn from Shefali’s experiences

The episode was first broadcast as a live webinar in June 2023.  Learn more about this webinar at https://mtechaccess.co.uk/market-access-for-digital-therapies/

Learn how Mtech Access can support you with your market access journey at: https://mtechaccess.co.uk/global-market-access-and-pricing/ 

Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

Send us a text

What does it take to bring a cannabinoid pharmaceutical to market?

We were delighted to welcome Michael Sassano (CEO – SOMAÍ Pharmaceuticals) as the first guest on our new Global Whispers webinar series. Michael shared with us his company’s experiences bringing new products to market, the challenges SOMAÍ Pharmaceuticals have faced and the lessons the Pharma industry can learn from their journey.

In the webinar, Clare asked Michael about:
- Drug development and clinical trial processes for medical cannabis products
 - Differences between the herbal medicines market and the Pharmaceutical market
 - Overcoming regulatory and reimbursement challenges
 - Finding the right place for cannabinoid medicines within existing pathways of care
 - Perceptions, pathways and routes to access in different markets
 - Lessons for the wider Pharma and Biotech industries

Learn more about this webinar and our guest speaker Michael Sassano at: https://mtechaccess.co.uk/global-market-access-journey-cannabinoid-pharmaceuticals/

Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

Send us a text

How will changes to the structure of primary care impact decision making?
How is the relationship between Integrated Care Boards (ICBs) and primary care stakeholders evolving? How will funding flows be impacted?

Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) is joined by Tim Goodson (Executive Officer, Dorset General Practice Alliance) to explore how primary care is evolving and what this means for decision making, funding, and relationships with industry.

Phil and Tim explore:

• The integration journey across primary care
• Evolving relationships and structures in primary care in the NHS
• Where decisions are made and who makes them
• How understanding commissioning priorities and funding flows can help Pharma and Medtech to identify decision makers and understand their needs

This episode was first broadcast as a live webinar on Friday 28th April 2023.
For more information please see: https://mtechaccess.co.uk/primary-care-integration-journey/.


Learn more about how Mtech Access UK NHS Insight services at: https://mtechaccess.co.uk/uk-nhs-insights/

Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

Send us a text

Is data the key to transforming healthcare systems and patient care?

What are the top priorities for digital transformation leaders in the NHS? How can Pharma and Medtech companies partner with the NHS to share data, transform services, and find smarter, faster way to improve patient care?

Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) is joined by Stephen Slough (Chief Digital Information Officer, NHS Dorset) to explore how, through the catalyst of partnership, new technologies and data have the potential to transform healthcare.

We have reached a point where digital is so ubiquitous that, even in the NHS, what were previously seen as ‘digital’ transformation projects are now viewed as simply business transformation projects.

Add in advancements in artificial intelligence and ChatGPT-type services, along with the potential of big data, and it’s no surprise that digital is at the heart of transformation in the NHS.

In this episode, Phil and Stephen explore:

 - The digital landscape for NHS decision makers
 - How, when and where data can transform healthcare systems and patient care
 - How the NHS and industry can get access to and share our data to better plan products and services
 - What the top priorities are for digital leaders
 - How industry build strategic partnerships with Integrated Care Boards (ICBs) and other NHS leaders driving data-led transformation

This podcast was originally broadcast as a live webinar. Learn more at: https://mtechaccess.co.uk/data-led-transformation-nhs/

To learn more about our work with the NHS and how we support our Pharma and Medtech clients visit:  https://mtechaccess.co.uk/uk-nhs-insights/

Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence